The recent appointment of a medical device sales expert puts OxySure Systems, Inc (OXYS) on the radar. The move to appoint Clark Hood as V.P. of Worldwide Resuscitation Sales may not have an immediate impact but looks like a great move in the short-term for OXYS.
According to a recent OXYS press release, Hood was instrumental in boosting sales over 1,300%, to $20 million annually for a previous employer Survivalink. With over 25 years experience in the medical device industry, including extensive market contacts, he could impact sales quickly for OxySure Systems, Inc.
OxySure Systems, Inc. is a medical technology company that designs, manufactures and distributes respiratory and emergency medical solutions. According to the OXYS Company Fact Sheet the OxySure Model 615 has a strong market position as evidenced by eight consecutive quarters of double digit growth. Many analysts, including Zacks Small-Cap Research, Taglich Brothers and Sterling Investment all indicate strong share price upside. Target prices ranged from $1.50 to $2.10 per share.
According to an uncompensated and very thorough OXYS company report dated May 7, 2014, SeeThruEquity, LLC announced a price target of $1.27 per share. OXYS is currently trading at $0.85 per share with a 52-week range of $0.51 to $0.91 per share. With a small float of 3 million shares OXYS stock could experience some big moves with any good news in coming quarterly revenue filings.
Stay tuned TKO’ers!
http://finance.yahoo.com/q?s=oxys
The post OxySure Systems, Inc. (OXYS) Stock Watch appeared first on TKO Stocks.